🇺🇸 FDA

Drug profile · INN

rimegepant

VYDURA

FDA: approved EMA: approved N02CD06
US status
approved
Patents linked
0
News articles
0

Quick answer

rimegepant (VYDURA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN rimegepant
Brand VYDURA
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING
ATC code N02CD06

Frequently asked questions

What is rimegepant?

rimegepant (VYDURA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for rimegepant?

VYDURA is a marketed brand name for rimegepant. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of rimegepant?

rimegepant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.